Works matching IS 2397768X AND DT 2022 AND VI 6 AND IP 1

Results: 102
    1

    Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00339-8
    By:
    • Perez-Villatoro, Fernando;
    • Oikkonen, Jaana;
    • Casado, Julia;
    • Chernenko, Anastasiya;
    • Gulhan, Doga C.;
    • Tumiati, Manuela;
    • Li, Yilin;
    • Lavikka, Kari;
    • Hietanen, Sakari;
    • Hynninen, Johanna;
    • Haltia, Ulla-Maija;
    • Tyrmi, Jaakko S.;
    • Laivuori, Hannele;
    • Konstantinopoulos, Panagiotis A.;
    • Hautaniemi, Sampsa;
    • Kauppi, Liisa;
    • Färkkilä, Anniina
    Publication type:
    Article
    2
    3

    The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00337-w
    By:
    • Criscione, Steven W.;
    • Martin, Matthew J.;
    • Oien, Derek B.;
    • Gorthi, Aparna;
    • Miragaia, Ricardo J.;
    • Zhang, Jingwen;
    • Chen, Huawei;
    • Karl, Daniel L.;
    • Mendler, Kerrin;
    • Markovets, Aleksandra;
    • Gagrica, Sladjana;
    • Delpuech, Oona;
    • Dry, Jonathan R.;
    • Grondine, Michael;
    • Hattersley, Maureen M.;
    • Urosevic, Jelena;
    • Floc'h, Nicolas;
    • Drew, Lisa;
    • Yao, Yi;
    • Smith, Paul D.
    Publication type:
    Article
    4
    5
    6

    Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00334-z
    By:
    • Lee, Jessica K.;
    • Sivakumar, Smruthy;
    • Schrock, Alexa B.;
    • Madison, Russell;
    • Fabrizio, David;
    • Gjoerup, Ole;
    • Ross, Jeffrey S.;
    • Frampton, Garrett M.;
    • Napalkov, Pavel;
    • Montesion, Meagan;
    • Schutzman, Jennifer L.;
    • Ye, Xin;
    • Hegde, Priti S.;
    • Nagasaka, Misako;
    • Oxnard, Geoffrey R.;
    • Sokol, Ethan S.;
    • Ou, Sai-Hong Ignatius;
    • Shi, Zhen
    Publication type:
    Article
    7
    8

    Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00335-y
    By:
    • Peterziel, Heike;
    • Jamaladdin, Nora;
    • ElHarouni, Dina;
    • Gerloff, Xenia F.;
    • Herter, Sonja;
    • Fiesel, Petra;
    • Berker, Yannick;
    • Blattner-Johnson, Mirjam;
    • Schramm, Kathrin;
    • Jones, Barbara C.;
    • Reuss, David;
    • Turunen, Laura;
    • Friedenauer, Aileen;
    • Holland-Letz, Tim;
    • Sill, Martin;
    • Weiser, Lena;
    • Previti, Christopher;
    • Balasubramanian, Gnanaprakash;
    • Gerber, Nicolas U.;
    • Gojo, Johannes
    Publication type:
    Article
    9
    10
    11
    12
    13

    Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00322-3
    By:
    • Hindocha, Sumeet;
    • Charlton, Thomas G.;
    • Linton-Reid, Kristofer;
    • Hunter, Benjamin;
    • Chan, Charleen;
    • Ahmed, Merina;
    • Greenlay, Emily J.;
    • Orton, Matthew;
    • Bunce, Catey;
    • Lunn, Jason;
    • Doran, Simon J.;
    • Ahmad, Shahreen;
    • McDonald, Fiona;
    • Locke, Imogen;
    • Power, Danielle;
    • Blackledge, Matthew;
    • Lee, Richard W.;
    • Aboagye, Eric O.
    Publication type:
    Article
    14

    Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
    By:
    • Vo, Henry Hiep;
    • Fu, Siqing;
    • Hong, David S.;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Naing, Aung;
    • Yap, Timothy A.;
    • Rodon, Jordi;
    • Ajani, Jaffer A.;
    • Cartwright, Carrie;
    • Johnson, Amber;
    • Song, I-Wen;
    • Beck, Jennifer;
    • Kahle, Michael;
    • Nogueras-Gonzalez, Graciela M.;
    • Miller, Vincent;
    • Chao, Calvin;
    • Vining, David J.
    Publication type:
    Article
    15
    16

    Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00326-z
    By:
    • Chabot, Thomas;
    • Nemati, Fariba;
    • Herbette, Aurélie;
    • Demeyer, Alexandre;
    • Dayot, Stéphane;
    • Ganier, Olivier;
    • Alsafadi, Samar;
    • Gardrat, Sophie;
    • Mariani, Pascale;
    • Luporsi, Marie;
    • Corbé, Maxime;
    • Servois, Vincent;
    • Cassoux, Nathalie;
    • Decaudin, Didier;
    • Roman, Sergio Roman;
    • Del Nery, Elaine;
    • Piperno-Neumann, Sophie;
    • Stern, Marc-Henri;
    • Rodrigues, Manuel
    Publication type:
    Article
    17
    18

    Prediction of early-stage melanoma recurrence using clinical and histopathologic features.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00321-4
    By:
    • Wan, Guihong;
    • Nguyen, Nga;
    • Liu, Feng;
    • DeSimone, Mia S.;
    • Leung, Bonnie W.;
    • Rajeh, Ahmad;
    • Collier, Michael R.;
    • Choi, Min Seok;
    • Amadife, Munachimso;
    • Tang, Kimberly;
    • Zhang, Shijia;
    • Phillipps, Jordan S.;
    • Jairath, Ruple;
    • Alexander, Nora A.;
    • Hua, Yining;
    • Jiao, Meng;
    • Chen, Wenxin;
    • Ho, Diane;
    • Duey, Stacey;
    • Németh, István Balázs
    Publication type:
    Article
    19

    Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00327-y
    By:
    • de Bitter, Tessa J. J.;
    • de Reuver, Philip R.;
    • de Savornin Lohman, Elise A. J.;
    • Kroeze, Leonie I.;
    • Vink-Börger, Marianne E.;
    • van Vliet, Shannon;
    • Simmer, Femke;
    • von Rhein, Daniel;
    • Jansen, Erik A. M.;
    • Verheij, Joanne;
    • van Herpen, Carla M. L.;
    • Nagtegaal, Iris D.;
    • Ligtenberg, Marjolijn J. L.;
    • van der Post, Rachel S.
    Publication type:
    Article
    20

    Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00324-1
    By:
    • Kohsaka, Shinji;
    • Tada, Yuichiro;
    • Ando, Mizuo;
    • Nakaguro, Masato;
    • Shirai, Yukina;
    • Ueno, Toshihide;
    • Kojima, Shinya;
    • Hirai, Hideaki;
    • Saigusa, Natsuki;
    • Kano, Satoshi;
    • Tsukahara, Kiyoaki;
    • Togashi, Takafumi;
    • Ozawa, Hiroyuki;
    • Kondo, Takahito;
    • Okami, Kenji;
    • Takahashi, Hideaki;
    • Kawakita, Daisuke;
    • Fushimi, Chihiro;
    • Suzuki, Takayoshi;
    • Shimizu, Akira
    Publication type:
    Article
    21
    22
    23

    A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00262-y
    By:
    • Rajakumar, Timothy;
    • Horos, Rastislav;
    • Jehn, Julia;
    • Schenz, Judith;
    • Muley, Thomas;
    • Pelea, Oana;
    • Hofmann, Sarah;
    • Kittner, Paul;
    • Kahraman, Mustafa;
    • Heuvelman, Marco;
    • Sikosek, Tobias;
    • Feufel, Jennifer;
    • Skottke, Jasmin;
    • Nötzel, Dennis;
    • Hinkfoth, Franziska;
    • Tikk, Kaja;
    • Daniel-Moreno, Alberto;
    • Ceiler, Jessika;
    • Mercaldo, Nathaniel;
    • Uhle, Florian
    Publication type:
    Article
    24
    25
    26

    HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
    By:
    • Tanimura, Keiko;
    • Yamada, Tadaaki;
    • Okada, Koutaroh;
    • Nakai, Kunihiro;
    • Horinaka, Mano;
    • Katayama, Yuki;
    • Morimoto, Kenji;
    • Ogura, Yuri;
    • Takeda, Takayuki;
    • Shiotsu, Shinsuke;
    • Ichikawa, Kosuke;
    • Watanabe, Satoshi;
    • Morimoto, Yoshie;
    • Iwasaku, Masahiro;
    • Kaneko, Yoshiko;
    • Uchino, Junji;
    • Taniguchi, Hirokazu;
    • Yoneda, Kazue;
    • Matoba, Satoaki;
    • Sakai, Toshiyuki
    Publication type:
    Article
    27
    28

    Functional characterization of NPM1–TYK2 fusion oncogene.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00246-4
    By:
    • Kuravi, Sudhakiranmayi;
    • Baker, Riley W.;
    • Mushtaq, Muhammad Umair;
    • Saadi, Irfan;
    • Lin, Tara L.;
    • Vivian, Carolyn J.;
    • Valluripalli, Anusha;
    • Abhyankar, Sunil;
    • Ganguly, Siddhartha;
    • Cui, Wei;
    • Elenitoba-Johnson, Kojo S. J.;
    • Welch, Danny R.;
    • Jensen, Roy A.;
    • Saunthararajah, Yogen;
    • McGuirk, Joseph P.;
    • Balusu, Ramesh
    Publication type:
    Article
    29
    30

    Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14).

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00315-2
    By:
    • Nguyen, Nina;
    • Chaudhry, Sana;
    • Totiger, Tulasigeri M.;
    • Diaz, Robert;
    • Roberts, Evan;
    • Montoya, Skye;
    • Pardo, Gabriel;
    • Pardo, Alejandro;
    • Afaghani, Jumana;
    • Affer, Maurizio;
    • Jahn, Jacob;
    • Bradley, Terrence;
    • Maura, Francesco;
    • Kazandjian, Dickran;
    • Bilbao, Daniel;
    • Chapman, Jennifer;
    • Landgren, Ola;
    • Hoffman, James;
    • Taylor, Justin
    Publication type:
    Article
    31

    A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00318-z
    By:
    • Spurr, Liam F.;
    • Martinez, Carlos A.;
    • Katipally, Rohan R.;
    • Iyer, Soumya C.;
    • Pugh, Sian A.;
    • Bridgewater, John A.;
    • Primrose, John N.;
    • Domingo, Enric;
    • Maughan, Timothy S.;
    • D'Angelica, Michael I.;
    • Talamonti, Mark;
    • Posner, Mitchell C.;
    • Connell, Philip P.;
    • Weichselbaum, Ralph R.;
    • Pitroda, Sean P.
    Publication type:
    Article
    32
    33
    34

    MatchMiner: an open-source platform for cancer precision medicine.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00312-5
    By:
    • Klein, Harry;
    • Mazor, Tali;
    • Siegel, Ethan;
    • Trukhanov, Pavel;
    • Ovalle, Andrea;
    • Vecchio Fitz, Catherine Del;
    • Zwiesler, Zachary;
    • Kumari, Priti;
    • Van Der Veen, Bernd;
    • Marriott, Eric;
    • Hansel, Jason;
    • Yu, Joyce;
    • Albayrak, Adem;
    • Barry, Susan;
    • Keller, Rachel B.;
    • MacConaill, Laura E.;
    • Lindeman, Neal;
    • Johnson, Bruce E.;
    • Rollins, Barrett J.;
    • Do, Khanh T.
    Publication type:
    Article
    35
    36
    37
    38

    An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00307-2
    By:
    • Shulman, David S.;
    • Whittle, Sarah B.;
    • Surdez, Didier;
    • Bailey, Kelly M.;
    • de Álava, Enrique;
    • Yustein, Jason T.;
    • Shlien, Adam;
    • Hayashi, Masanori;
    • Bishop, Alexander J. R.;
    • Crompton, Brian D.;
    • DuBois, Steven G.;
    • Shukla, Neerav;
    • Leavey, Patrick J.;
    • Lessnick, Stephen L.;
    • Kovar, Heinrich;
    • Delattre, Olivier;
    • Grünewald, Thomas G. P.;
    • Antonescu, Cristina R.;
    • Roberts, Ryan D.;
    • Toretsky, Jeffrey A.
    Publication type:
    Article
    39

    Impact of TP53 mutations in Triple Negative Breast Cancer.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00303-6
    By:
    • Mitri, Zahi I.;
    • Abuhadra, Nour;
    • Goodyear, Shaun M.;
    • Hobbs, Evthokia A.;
    • Kaempf, Andy;
    • Thompson, Alastair M.;
    • Moulder, Stacy L.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    Spatially variant immune infiltration scoring in human cancer tissues.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00305-4
    By:
    • Allam, Mayar;
    • Hu, Thomas;
    • Lee, Jeongjin;
    • Aldrich, Jeffrey;
    • Badve, Sunil S.;
    • Gökmen-Polar, Yesim;
    • Bhave, Manali;
    • Ramalingam, Suresh S.;
    • Schneider, Frank;
    • Coskun, Ahmet F.
    Publication type:
    Article
    46

    Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00306-3
    By:
    • Bonner, Erin R.;
    • Harrington, Robin;
    • Eze, Augustine;
    • Bornhorst, Miriam;
    • Kline, Cassie N.;
    • Gordish-Dressman, Heather;
    • Dawood, Adam;
    • Das, Biswajit;
    • Chen, Li;
    • Pauly, Rini;
    • Williams, P. Mickey;
    • Karlovich, Chris;
    • Peach, Amanda;
    • Howell, D'andra;
    • Doroshow, James;
    • Kilburn, Lindsay;
    • Packer, Roger J.;
    • Mueller, Sabine;
    • Nazarian, Javad
    Publication type:
    Article
    47
    48
    49
    50